01.30.24 -- A Brief Introduction To Environmental Monitoring For Startups

Take your viral vector production to a commercial scale with the right production system and single-use bioreactor combination.

Discover an efficient, data-driven process that employs innovative methods to accelerate the selection of a closure containment system that meets the requirements of the modern regulatory landscape.

Fluid bed and melt granulation represent an opportunity for drug developers to achieve appreciable efficiency gains in their processes, as well as measurable improvements in their final drug products.

Find out how you can accelerate the time to patients for new vaccines and therapies with innovative, streamlined technology that is quicker and more intuitive.

The transition from academic research and studies to industry research demands that individuals master additional skills, set different objectives, and define “success” differently.

Learn about the headspace gas ingress testing approach, which is increasingly being implemented to replace blue dye ingress as a general CCI test method.

When preparing for IND submission, developers must consider multiple components. Explore tips for optimizing your early development program and the benefits of housing all activities under one roof.

Delivering supplies and biospecimens to remote areas demands an experienced logistics partner. Learn how state-of-the-art technology streamlined the supply chain process for a remote clinical trial.

In analytical environments, precise weighing takes place inside containment where powders do not escape. Here, we measure the effectiveness of three vibration isolation strategies.

Discover how strategic partnerships, robust process development, and a keen awareness of supply chain vulnerabilities can pave the way to a successful clinical trial.

Delve into four articles regarding dissecting the critical resources, processes, and key stakeholders essential for the successful completion of an ACT clinical trial.

The antibody-drug conjugate manufacturing supply chain contains five different technologies with specific asset needs: monoclonal antibody, cytotoxic payload, linker, bioconjugation, and fill/finish.

Learn how embracing digital transformation through the use of distributed automation and digital plant maturity can support productivity, efficiency, and resilience in biomanufacturing.

How do active purging pass-throughs offer a higher level of material control for cell and gene therapy facilities?

Explore the advantages offered by the freeze-dried Zydis ODT relating to large molecule storage, aggregation, and in some cases, protease activity.